XNPT : Insider Transactions for Xenoport Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Xenoport Inc (XNPT)

$0.00 0.00 (0.00%) as of 4:30 Fri 2/14

Download

Exchange:

Nasdaq National Market

Security Type:

Common

Shares Out:

61,890,000

Market Cap:

N/A

Last Volume:

2,615,875

Avg Vol:

1,202,343

52 Week Range:

$7.07 - $7.07

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Drug Related Products

Member Indexes:

	NASDAQ BIOTECHNOLOGY		NASDAQ COMPOSITE
	NASDAQ NNM COMPOSITE

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


Company Profile

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-02-18	2023-11-17	2023-05-19	2022-05-19

Adjust Filter Settings

Records found: 663

Page 19 of 27

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

SVP, Research

• – –

2008-05-01

4

AS

$42.27

$119,203

I/I

(2,800)

138,453

-

Cundy Kenneth C

SVP, Preclinical Development

• – –

2008-04-04

4

AS

$44.15

$44,170

D/D

(1,000)

11,945

-

Cundy Kenneth C

SVP, Preclinical Development

• – –

2008-04-01

4

AS

$41.47

$42,087

D/D

(1,000)

12,945

-

Harris William G

SVP, Finance and CFO

• – –

2008-04-01

4

AS

$41.41

$42,059

D/D

(1,000)

37,710

-

SVP, Research

• – –

2008-04-01

4

AS

$41.43

$125,678

I/I

(3,000)

141,253

-

Director

– • –

2008-03-14

4

B

$42.05

$98,340

D/D

2,300

2,300

2.39

-

Freund John Gordon

Director

– • –

2008-03-14

4

B

$41.43

$112,690

D/D

2,720

2,720

2.39

-

Freund John Gordon

Director

– • –

2008-03-14

4

B

$41.24

$202,619

I/I

4,858

18,058

2.1

-

Cundy Kenneth C

SVP, Preclinical Development

• – –

2008-03-03

4

AS

$49.92

$136,883

D/D

(2,700)

14,245

-

Cundy Kenneth C

SVP, Preclinical Development

• – –

2008-03-03

4

AS

$50.35

$15,191

D/D

(300)

13,945

-

SVP, Research

• – –

2008-03-03

4

AS

$49.96

$147,063

I/I

(2,900)

145,353

-

SVP, Research

• – –

2008-03-03

4

AS

$49.96

$55,807

I/I

(1,100)

144,253

-

Harris William G

SVP, Finance and CFO

• – –

2008-03-03

4

AS

$49.96

$76,112

D/D

(1,500)

38,710

-

Barrett Ronald W

Chief Executive Officer

• • –

2008-02-19

4

AS

$53.16

$198,845

I/I

(3,664)

72,067

-

Barrett Ronald W

Chief Executive Officer

• • –

2008-02-19

4

D

$53.96

$120,601

D/D

(2,235)

8,776

-

Barrett Ronald W

Chief Executive Officer

• • –

2008-02-19

4

OE

$0.00

$0

D/D

6,250

11,011

-

Barrett Ronald W

Chief Executive Officer

• • –

2008-02-19

4

AS

$53.83

$70,181

I/I

(1,281)

70,786

-

Harris William G

SVP, Finance and CFO

• – –

2008-02-19

4

OE

$0.00

$0

D/D

834

40,210

-

Barrett Ronald W

Chief Executive Officer

• • –

2008-02-19

4

AS

$53.16

$165,759

I/I

(3,055)

75,731

-

Rieflin William Jl

President

• – –

2008-02-19

4

OE

$0.00

$0

D/D

1,459

7,284

-

SVP, Research

• – –

2008-02-19

4

D

$53.96

$16,134

D/D

(299)

14,861

-

SVP, Research

• – –

2008-02-19

4

OE

$0.00

$0

D/D

834

15,160

-

Cundy Kenneth C

SVP, Preclinical Development

• – –

2008-02-19

4

D

$53.96

$20,127

D/D

(373)

16,945

-

Cundy Kenneth C

SVP, Preclinical Development

• – –

2008-02-19

4

OE

$0.00

$0

D/D

1,043

17,318

-

Savello David R

SVP, Development

• – –

2008-02-19

4

OE

$0.00

$0

D/D

4,168

25,732

-

663 Records found	Previous 10 11 12 13 14 15 16 17 18 19 Next	Page 19 of 27

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.